Jon M. Foster - Jan 30, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and COO
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jan 30, 2023
Transactions value $
-$6,598,814
Form type
4
Date filed
2/1/2023, 06:57 PM
Previous filing
Feb 23, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $1.66M +24K +219.42% $68.96 34.9K Jan 30, 2023 Direct
transaction HCA Common Stock Options Exercise $832K +12K +34.22% $69.58 46.9K Jan 30, 2023 Direct
transaction HCA Common Stock Tax liability -$4.95M -19.5K -41.65% $253.30 27.4K Jan 30, 2023 Direct
transaction HCA Common Stock Sale -$4.14M -16.4K -60.02% $251.98 10.9K Feb 1, 2023 Direct F1
holding HCA Common Stock 49K Jan 30, 2023 By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
holding HCA Common Stock 49K Jan 30, 2023 By LCF Trust (Reporting Person, Trustee)
holding HCA Common Stock 20K Jan 30, 2023 By JMF Family Trust (Spouse, Trustee)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -24K -100% $0.00* 0 Jan 30, 2023 Common Stock 24K $68.96 Direct F2
transaction HCA Stock Appreciation Right Options Exercise $0 -12K -50% $0.00 12K Jan 30, 2023 Common Stock 12K $69.58 Direct F3
transaction HCA Stock Appreciation Right Award $0 +23.7K $0.00 23.7K Jan 30, 2023 Common Stock 23.7K $253.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.10 to $252.08, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.
F3 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
F4 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.